EUVIMEDEUVIMED entdecken
Crossref

FXR suppress Müller cell activation by regulating cGAS / STING pathway in diabetic retinopathy

Zi-Li Wang, Xin-Yu Zhang, Cheng-Ye Tan, Miao Zhuang, Lingpeng Zhu, Xin-Hua Zheng, Yong Yao iD, Ting-Ting Wei iD

The FEBS Journal · 2025

DOI: 10.1111/febs.17421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Zi-Li Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjin…. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Ependymoglial Cells, Receptors, Cytoplasmic and Nuclear, Membrane Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Wuxi Taihu Lake Talent Plan, General Program of Wuxi Medical Center, Top Talent Support Program for young and middle-aged (Double Hundred Medical Youth Professionals Program) from Wuxi Health Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy (DR) is widely acknowledged as an ocular complication of diabetes mellitus involving retinal inflammation and secondary neuro/microvascular degeneration. Müller glial cells play a crucial role in regulating retinal homeostasis and neuroinflammation within the retina. Farnesoid X nuclear receptor (FXR) has emerged as a potential regulator of metabolic homeostasis and inflammatory responses as a bile acid nuclear receptor. However, its precise role in DR remains unclear. In order to investigate the effect of FXR on DR, we employed Sprague‐Dawley rats treated with streptozotocin (STZ) and human Müller glial cells treated with advanced glycation end products (AGEs) or high glucose with palmitate (HG + PA). Our investigations revealed downregulation of FXR in DR. Furthermore, we demonstrated that activating FXR could mitigate the progression of DR, with its protective effects linked to the inhibition of inflammatory responses within Müller cells. Mechanistically, FXR could ameliorate mitochondrial dysfunction and suppress the opening of the mitochondrial permeability transition pore. This action blocked the release of mitochondrial DNA (mtDNA) from the mitochondria into the cytoplasm, thereby inhibiting the abnormal activation of the cGAS/STING pathway in DR. Further studies revealed that FXR upregulates mitochondrial transcription factor A (TFAM) by modulating ATF4/NRF1, ultimately enhancing mitochondrial function. Knockdown of FXR reversed the above effects. Additionally, FXR activation effectively rescued mitochondrial dysfunction, as evidenced by Tunicamycin (TUN)‐mediated assays, further validating our findings. In summary, our findings suggest that targeting FXR may offer promising strategies for future therapeutic interventions in the treatment of DR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyEpendymoglial CellsReceptors, Cytoplasmic and NuclearMembrane ProteinsNucleotidyltransferasesAnimalsRatsHumansRats, Sprague-DawleySignal TransductionDiabetes Mellitus, ExperimentalMaleMitochondriaGlycation End Products, AdvancedStreptozocinRetinaGlucoseReceptor, Farnesoid X-ActivatedCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Stichwörter der Autor:innen

ATF4/NRF1/TFAMFXRcGAS/STINGdiabetic retinopathymitochondrial dysfunction

Substanzen

Receptors, Cytoplasmic and NuclearMembrane ProteinsNucleotidyltransferasesGlycation End Products, AdvancedStreptozocinGlucoseReceptor, Farnesoid X-ActivatedcGAS protein, humanCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Autor:innen und Institutionen

  • Department of Ophthalmology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China.
  • Center of Clinical Research, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China.
  • Department of Ophthalmology, Affiliated Children's Hospital of Jiangnan University, Wuxi Children's Hospital, Wuxi, China.

ORCID-Profile: Yong Yao, Ting-Ting Wei

Förderung

  • Wuxi Taihu Lake Talent Plan
  • General Program of Wuxi Medical Center
  • Top Talent Support Program for young and middle-aged (Double Hundred Medical Youth Professionals Program) from Wuxi Health Committee
  • Basic Research Program of Jiangsu Province
  • National Natural Science Foundation of China
  • Youth Project of Wuxi Municipal Health Commission

Zitieren

APA

Wang, Z. L., Zhang, X. Y., Tan, C. Y., Zhuang, M., Zhu, L., Zheng, X. H., Yao, Y., & Wei, T. T. (2025). FXR suppress Müller cell activation by regulating cGAS / STING pathway in diabetic retinopathy. The FEBS Journal. https://doi.org/10.1111/febs.17421

Vancouver

Wang ZL, Zhang XY, Tan CY, Zhuang M, Zhu L, Zheng XH, et al. FXR suppress Müller cell activation by regulating cGAS / STING pathway in diabetic retinopathy. The FEBS Journal. 2025. doi:10.1111/febs.17421

BibTeX
@article{Wang2025,
  author = {Wang, Zi-Li and Zhang, Xin-Yu and Tan, Cheng-Ye and Zhuang, Miao and Zhu, Lingpeng and Zheng, Xin-Hua and Yao, Yong and Wei, Ting-Ting},
  title = {FXR suppress Müller cell activation by regulating cGAS / STING pathway in diabetic retinopathy},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.17421}
}
Kostenlos starten →